ILMN teams up with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data.

Claro Advisors LLC lessened its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Illumina (ILMN), which belongs to the Zacks ...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $144.22 which represents a slight increase of $7.53 or 5.51% from the prior close of $136.69. The stock opened at $137 and touched a ...

In a report released today, Tejas Savant from Morgan Stanley maintained a Hold rating on Illumina (ILMN – Research Report), with a price target ...

ILMN.

Bernstein analyst Eve Burstein maintained a Hold rating on Illumina (ILMN – Research Report) today. The company’s shares opened today at ...

Genomics is becoming the future of medicine as technological advancements continue to unlock our DNA’s vast potential. Given ...

Buying $100 In ILMN: If an investor had bought $100 of ILMN stock 20 years ago, it would be worth $3,290.99 today based on a ...

Stock analysts at Leerink Partnrs decreased their Q4 2025 earnings per share (EPS) estimates for Illumina in a note issued to ...

Illumina, Inc. ILMN has announced a series of updates to its NovaSeq X Series. The company’s single-flow-cell NovaSeq X Sequencing System is now available for the first time, alongside the ...